Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

06 June 2014 : Research paper  

Viability changes: Microbiological analysis of dental casts

Juozas ŽilinskasACDEF, Jonas JunevičiusCF, Agnė RamonaitėCF, Alvydas PavilonisEF, Alvydas GleiznysEF, Jurgina SakalauskienėCDF

DOI: 10.12659/MSM.890500

Med Sci Monit 2014; 20:932-937

Abstract

BACKGROUND: This study evaluated the survival of the most prevalent oral bacteria and fungi (Staphylococcus aureus, Klebsiella pneumoniae, Escherichia coli, and Candida albicans) in dental casts, and compared changes in the amounts of these microorganisms at different time intervals to determine how long dental casts may pose threat to the health of dental personnel and patients.

MATERIAL AND METHODS: When manufacturing the casts, regular water was replaced with sterile distilled water, where suspensions of the studied bacteria or the fungus at certain concentrations were prepared. When the dental casts were fully set (solidified), plaster shavings were examined immediately after the contact of the studied microorganism with the plaster, as well as after 1, 2, 24, 48, 72, 96, and 120 hours. Following that, we measured how the amount of the studied bacteria and fungi in 1 gram of the plaster changed within the studied period of time.

RESULTS: Klebsiella pneumoniae survived in plaster for up to 4 days, and the reduction in the number of these bacteria became statistically significant after 1 day (p<0.05). Staphylococcus aureus remained viable in plaster for up to 4 days, and the number of these bacteria dropped after 1 day (p<0.05). Escherichia coli disappeared after 2 days, and a reduction was already observed after 2 hours (p<0.05). Candida albicans in plaster models died within 2 days, and a reduction in their number was observed after 1 day (p<0.05).

CONCLUSIONS: The microorganisms did not multiply in the gypsum casts and their number significantly dropped instead of increasing.

Keywords: Bacteria - growth & development, Candida albicans - growth & development, Colony Count, Microbial, Dental Implants - microbiology, Escherichia coli - growth & development, Fungi - growth & development, Klebsiella pneumoniae - physiology, Microbial Viability, Staphylococcus aureus - physiology

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750